Deutsche Märkte geschlossen

Amneal Pharmaceuticals, Inc. (2DT.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
5,75+0,10 (+1,77%)
Börsenschluss: 03:29PM CEST

Insider

Person oder EinheitLetzte TransaktionDatumAktienbesitz Stand Transaktionsdatum

AUTOR DEBORAH M
Director

Conversion of Exercise of derivative security

28. Juli 2023

54.949

BOYER ANDREW S
Officer

Conversion of Exercise of derivative security

01. März 2024

319.381

BUCHI J. KEVIN
Director

Conversion of Exercise of derivative security

10. Mai 2023

185.619

DALY JASON B.
Officer

Conversion of Exercise of derivative security

01. März 2024

57.322

KONIDARIS TASOS
Chief Financial Officer

Conversion of Exercise of derivative security

12. März 2024

527.316

MEISTER PAUL M
Director

Conversion of Exercise of derivative security

10. Mai 2023

620.658

NARK THEODORE C.
Director

Conversion of Exercise of derivative security

10. Mai 2023

224.318

PATEL GAUTAM
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase

01. Dez. 2023

16.219.500

SHAH NIKITA
Officer

Conversion of Exercise of derivative security

01. März 2024

391.666

YANAI SHLOMO
Director

Conversion of Exercise of derivative security

10. Mai 2023

169.274

* Insider-Daten werden ausschließlich aus Formular 3 und Formular 4 der SEC-Einreichungen der letzten 24 Monate bezogen.